OIL Stock Overview
Optiscan Imaging Limited develops and commercializes confocal microscopes for clinical and pre-clinical applications in Australia, Germany, and Internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Optiscan Imaging Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.13 |
| 52 Week High | AU$0.17 |
| 52 Week Low | AU$0.091 |
| Beta | 1.78 |
| 1 Month Change | 25.00% |
| 3 Month Change | -10.71% |
| 1 Year Change | -13.79% |
| 3 Year Change | 303.23% |
| 5 Year Change | 31.58% |
| Change since IPO | -37.50% |
Recent News & Updates
We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Jan 16
We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Sep 19Recent updates
We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Jan 16We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Sep 19We're Not Very Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Jun 10Optiscan Imaging (ASX:OIL) Is In A Strong Position To Grow Its Business
Dec 30We're Not Worried About Optiscan Imaging's (ASX:OIL) Cash Burn
Aug 02How Much Of Optiscan Imaging Limited (ASX:OIL) Do Insiders Own?
Mar 04Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?
Dec 02Shareholder Returns
| OIL | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 4.2% | -2.4% | 0.6% |
| 1Y | -13.8% | 2.2% | 3.5% |
Return vs Industry: OIL underperformed the Australian Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: OIL underperformed the Australian Market which returned 3.5% over the past year.
Price Volatility
| OIL volatility | |
|---|---|
| OIL Average Weekly Movement | 18.4% |
| Medical Equipment Industry Average Movement | 9.7% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 15.7% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: OIL is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 18% a week.
Volatility Over Time: OIL's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Camile Farah | https://www.optiscan.com |
Optiscan Imaging Limited develops and commercializes confocal microscopes for clinical and pre-clinical applications in Australia, Germany, and Internationally. It offers FIVE2 (ViewnVivo) system, a miniaturized confocal endomicroscopes use for clinical, translational, pre-clinical, and other research. The company also engages in the development of InVivage device for use in cancer screening and surgery.
Optiscan Imaging Limited Fundamentals Summary
| OIL fundamental statistics | |
|---|---|
| Market Cap | AU$78.29m |
| Earnings (TTM) | -AU$4.23m |
| Revenue (TTM) | AU$2.25m |
34.8x
P/S Ratio-18.5x
P/E RatioIs OIL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OIL income statement (TTM) | |
|---|---|
| Revenue | AU$2.25m |
| Cost of Revenue | AU$2.43m |
| Gross Profit | -AU$180.69k |
| Other Expenses | AU$4.05m |
| Earnings | -AU$4.23m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0068 |
| Gross Margin | -8.03% |
| Net Profit Margin | -188.22% |
| Debt/Equity Ratio | 0% |
How did OIL perform over the long term?
See historical performance and comparison